GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (XBRU:ONWD) » Definitions » EV-to-EBITDA

Onward Medical NV (XBRU:ONWD) EV-to-EBITDA : -4.39 (As of May. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Onward Medical NV EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Onward Medical NV's enterprise value is €149.17 Mil. Onward Medical NV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €-33.97 Mil. Therefore, Onward Medical NV's EV-to-EBITDA for today is -4.39.

The historical rank and industry rank for Onward Medical NV's EV-to-EBITDA or its related term are showing as below:

XBRU:ONWD' s EV-to-EBITDA Range Over the Past 10 Years
Min: -13.9   Med: 0   Max: 0
Current: -4.39

XBRU:ONWD's EV-to-EBITDA is ranked worse than
100% of 463 companies
in the Biotechnology industry
Industry Median: 9.32 vs XBRU:ONWD: -4.39

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-14), Onward Medical NV's stock price is €4.68. Onward Medical NV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.200. Therefore, Onward Medical NV's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Onward Medical NV EV-to-EBITDA Historical Data

The historical data trend for Onward Medical NV's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV EV-to-EBITDA Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - -8.20 -4.49 -2.37

Onward Medical NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.20 - -4.49 - -2.37

Competitive Comparison of Onward Medical NV's EV-to-EBITDA

For the Biotechnology subindustry, Onward Medical NV's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onward Medical NV's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's EV-to-EBITDA falls into.



Onward Medical NV EV-to-EBITDA Calculation

Onward Medical NV's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=149.169/-33.972
=-4.39

Onward Medical NV's current Enterprise Value is €149.17 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Onward Medical NV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €-33.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Onward Medical NV  (XBRU:ONWD) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Onward Medical NV's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.68/-1.200
=At Loss

Onward Medical NV's share price for today is €4.68.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Onward Medical NV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.200.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Onward Medical NV EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Onward Medical NV (XBRU:ONWD) Business Description

Traded in Other Exchanges
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (XBRU:ONWD) Headlines

No Headlines